Stoke Therapeutics, Inc. (STOK)
25.04
-0.66
(-2.57%)
USD |
NASDAQ |
Oct 23, 16:00
25.03
-0.01
(-0.04%)
After-Hours: 20:00
Stoke Therapeutics Market Cap : 1.563B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.563B |
| October 22, 2026 | 1.604B |
| October 21, 2026 | 1.602B |
| October 20, 2026 | 1.661B |
| October 19, 2026 | 1.549B |
| October 16, 2026 | 1.508B |
| October 15, 2026 | 1.536B |
| October 14, 2026 | 1.451B |
| October 13, 2026 | 1.404B |
| October 12, 2026 | 1.507B |
| October 09, 2026 | 1.544B |
| October 08, 2026 | 1.495B |
| October 07, 2026 | 1.516B |
| October 06, 2026 | 1.521B |
| October 05, 2026 | 1.580B |
| October 02, 2026 | 1.599B |
| October 01, 2026 | 1.623B |
| September 30, 2026 | 1.622B |
| September 29, 2026 | 1.615B |
| September 28, 2026 | 1.591B |
| September 25, 2026 | 1.548B |
| September 24, 2026 | 1.578B |
| September 23, 2026 | 1.629B |
| September 22, 2026 | 1.822B |
| September 21, 2026 | 1.750B |
| Date | Value |
|---|---|
| September 18, 2026 | 1.774B |
| September 17, 2026 | 1.805B |
| September 16, 2026 | 1.742B |
| September 15, 2026 | 1.757B |
| September 14, 2026 | 1.847B |
| September 11, 2026 | 1.812B |
| September 10, 2026 | 1.831B |
| September 09, 2026 | 1.867B |
| September 08, 2026 | 1.875B |
| September 04, 2026 | 1.860B |
| September 03, 2026 | 1.871B |
| September 02, 2026 | 1.903B |
| September 01, 2026 | 1.928B |
| August 31, 2026 | 1.947B |
| August 28, 2026 | 1.973B |
| August 27, 2026 | 2.034B |
| August 26, 2026 | 2.065B |
| August 25, 2026 | 2.088B |
| August 24, 2026 | 2.017B |
| August 21, 2026 | 2.015B |
| August 20, 2026 | 1.959B |
| August 19, 2026 | 2.061B |
| August 18, 2026 | 2.006B |
| August 17, 2026 | 2.005B |
| August 14, 2026 | 1.951B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 269.76M |
| Amgen, Inc. | 237.46B |
| Anika Therapeutics, Inc. | 286.66M |
| BioCryst Pharmaceuticals, Inc. | 1.953B |
| Imunon, Inc. | 5.762M |
Market Cap Related Metrics
| PS Ratio | 55.84 |
| Price to Book Value | 4.522 |
| Price | 25.04 |
| Earnings Yield | -13.47% |